Beihai Gofar Chuanshan Biological Co Ltd
600538
Company Profile
Business description
Beihai Gofar Chuanshan Biological Co Ltd main business include pharmaceutical manufacturing and pharmaceutical distribution industry, judicial IVD (in vitro diagnostic) technology services, molecular medical imaging centers and tumor radiotherapy centers and tumor telemedicine technology services, etc.
Contact
No. 3, Beibuwan Middle Road
Guangxi Zhuang Autonomous Region
BeihaiGuangxi536000
CHNT: +86 7793200619
Sector
Basic Materials
Stock type
Cyclical
Industry
Agricultural Inputs
Fiscal Year End
31 December 2026
Employees
438
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
Microsoft’s earnings report is expected to touch on AI adoption and monetization.
stocks
World’s largest miner overvalued after solid quarter
The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.
stocks
Hidden value in an expensive ASX
How investors can uncover value beyond the index heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,999.20 | 52.20 | -0.58% |
| CAC 40 | 8,156.43 | 79.28 | -0.96% |
| DAX 40 | 24,194.90 | 75.97 | -0.31% |
| Dow JONES (US) | 49,490.03 | 340.65 | 0.69% |
| FTSE 100 | 10,476.46 | 21.63 | -0.21% |
| HKSE | 25,870.37 | 292.87 | -1.12% |
| NASDAQ | 24,657.57 | 397.60 | 1.64% |
| Nikkei 225 | 59,009.00 | 576.86 | -0.97% |
| NZX 50 Index | 12,872.34 | 73.26 | -0.57% |
| S&P 500 | 7,137.90 | 73.89 | 1.05% |
| S&P/ASX 200 | 8,768.10 | 51.40 | -0.58% |
| SSE Composite Index | 4,073.71 | 32.54 | -0.79% |